ライフサイエンスコーパス: paracentesis

1 nly 1 patient (SOC group) after large-volume paracentesis.

2 anterior chamber (AC) via peripheral corneal paracentesis.

3 ents undergoing therapeutic anterior chamber paracentesis.

4 vatively and 59 patients received additional paracentesis.

5 on systemic hemodynamics at patients' first paracentesis.

6 04), and 6 hours (+6 mmHg); p = 0.050) after paracentesis.

7 between first symptoms and implementation of paracentesis.

8 er current standard therapy with and without paracentesis.

9 r refractory ascites frequently necessitates paracentesis.

10 ), and 6 hours (6; IQR 4-6; p = 0.012) after paracentesis.

11 5/m2; p = 0.016) when measured 2 hours after paracentesis.

12 een first symptoms and the implementation of paracentesis.

13 because of PCR results from anterior chamber paracentesis.

14 and improves outcome following large volume paracentesis.

15 line and at key time points during and after paracentesis.

16 and (3) the resources used for large-volume paracentesis.

17 opriate when experienced personnel carry out paracentesis.

18 ys was observed in 26.7% of patients without paracentesis, 36.4% of patients with paracentesis within

19 ypropylene), and vitreous strand at inferior paracentesis (5.3%).

20 50 patients with sterile ascites on initial paracentesis, 7 patients developed peritonitis during fo

21 ted in charts, were common for patients with paracentesis after diagnosis with ascites, patients that

22 alopathy, and long-term (>3 months) need for paracentesis after TIPS placement were evaluated and cal

23 atedly administered topically 3 hours before paracentesis and continued for 90 minutes afterward.

24 ined as survival with no further therapeutic paracentesis and decreased ascites.

25 management change based on anterior chamber paracentesis and PCR.

26 the absence of any tangible effectiveness of paracentesis and the inherent risks of paracentesis such

27 had a complete response (required no further paracentesis) and 11 patients (22%) had a partial respon

28 ast year of life (not involving large-volume paracentesis), and number of large-volume paracentesis p

29 een proposed, including cataract extraction, paracentesis, and argon laser iridoplasty.

30 omes were alteration of treatment, safety of paracentesis, and correlation of keratitic precipitates

31 herapy to ascites [repeated thoracentesis or paracentesis, and transjugular intrahepatic portosystemi

32 reated with ocular massage, anterior chamber paracentesis, and/or hemodilution (conservative treatmen

33 r placement; lumbar puncture; thoracentesis; paracentesis; and intubation/mechanical ventilation) was

34 s with tense ascites undergoing large-volume paracentesis, as compared with alternative treatments in

35 standard in-patient therapy with and without paracentesis at the Dr.

36 patients with cirrhosis who had their first paracentesis at the Medical University of Vienna from 20

37 atients with (BCVA 1.9 +/- 0.31) and without paracentesis (BCVA 1.75 +/- 0.32) (p = 0.9), nor among t

38 utpatients with cirrhotic ascites undergoing paracentesis between July 1994 and December 2000.

39 In conclusion, large-volume paracentesis can be performed safely as an outpatient pr

40 2 L of drainage and 94.3 pg/mL at the end of paracentesis, compared with an increase of 10.5 pg/mL an

41 Four patients encountered paracentesis complications (4/53, 7.5%), 1 with long-ter

42 s were to determine (1) whether large-volume paracentesis could be performed safely and effectively b

43 is such as intraocular infection and injury, paracentesis does not appear to be warranted as a treatm

44 % for assays for cell number and type in the paracentesis fluid.

45 s ascites should be treated with therapeutic paracentesis followed by colloid volume expansion, and d

46 ponse (required less frequent but additional paracentesis for control of ascites).

47 A 10-L paracentesis improved abdominal discomfort and disclosed

48 and respiratory parameters before and after paracentesis in 50 critically ill patients with advanced

49 Paracentesis in critically ill patients is safe regardin

50 portosystemic shunts (TIPS) vis-a-vis total paracentesis in the management of refractory ascites is

51 een 2013 and 2015, who required large-volume paracentesis in their last year of life.

52 added gain in visual acuity by performing a paracentesis, independent of the time elapsed between fi

53 Beta-blockade has been associated with paracentesis-induced circulatory dysfunction.

54 perhaps related to beta-blockade associated paracentesis-induced circulatory dysfunction.

55 randomized to TIPS or repeated large volume paracentesis (LVP) for refractory ascites.

56 anges in serum NT-proBNP during large volume paracentesis (LVP) in patients with ascites have never b

57 ithin 7-24 hours, and 23.1% of patients with paracentesis more than 24 hours after the onset of sympt

58 py (sodium restriction, diuretics, and total paracentesis) (n = 57) or medical therapy plus TIPS (n =

59 nd detector electrodes on the abdomen during paracentesis of 8-11 L.

60 After paracentesis of the anterior eye chamber, the lacunae be

61 our study was to investigate the effects of paracentesis on hemodynamic and respiratory parameters i

62 er disease and tense ascites who performed a paracentesis on himself and developed K. kingae peritoni

63 nd time course of changes observed following paracentesis or diuretic therapy.

64 ascites is managed by repeated large volume paracentesis or insertion of a transjugular intrahepatic

65 hy, ascites requiring sustained diuretics or paracentesis, or coagulopathy unresponsive to vitamin K

66 - 0.32) (p = 0.9), nor among the groups with paracentesis (p = 0.8).

67 est and could forego the need for diagnostic paracentesis, particularly in cases where the cause of a

68 AO) such as ocular massage, anterior chamber paracentesis, physical exercise, and medication-induced

69 tesis ratio (number of day-case large-volume paracentesis procedures as a proportion of the total num

70 rrelated with the proportion of large-volume paracentesis procedures done in a day-case (vs unplanned

71 me paracentesis), and number of large-volume paracentesis procedures in the last year of life.

72 day-case paracentesis service (care group), paracentesis ratio (number of day-case large-volume para

73 One patient experienced a paracentesis related complication (1/45, 2.2 %) without

74 An ultrasound guided, transvaginal paracentesis removed 4 liters of straw-colored fluid, re

75 ife to death, whether enrolled in a day-case paracentesis service (care group), paracentesis ratio (n

76 atients who attended a day-case large-volume paracentesis service within their last year of life had

77 RPRETATION: The use of day-case large-volume paracentesis services in the last year of life was assoc

78 For paracentesis studies, vehicle, BOL-303242-X (0.1%, 0.5%,

79 In the paracentesis study, BOL-303242-X and DEX improved ocular

80 ss of paracentesis and the inherent risks of paracentesis such as intraocular infection and injury, p

81 Large-volume paracentesis, the preferred treatment for patients with

82 Three eyes required paracentesis to reduce the intraocular pressure after in

83 with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostat

84 mong those currently under investigation are paracentesis, ultrafiltration, peritoneal dialysis, oral

85 The mean duration of large-volume paracentesis was 97 +/- 24 minutes, and the mean volume

86 The long-term need for paracentesis was greater in the 8-mm group (64 of 111 pa

87 A paracentesis was performed after 48 hours of treatment.

88 The need for large-volume paracentesis was significantly reduced in GDP group, com

89 xperimental chickens subjected to unilateral paracentesis were fixed either by perfusion or in situ,

90 and respiratory parameters before and after paracentesis were performed by Wilcoxon signed-rank test

91 history, physical evaluation, and abdominal paracentesis with ascitic fluid analysis.

92 Anterior chamber paracentesis with PCR had a relatively low diagnostic ut

93 Anterior chamber paracentesis with PCR of aqueous fluid.

94 erior and posterior uveitis who underwent AC paracentesis with PCR were reviewed.

95 erior uveitis who underwent anterior chamber paracentesis with PCR.

96 ta-analyses on trials comparing large-volume paracentesis with transjugular intrahepatic portosystemi

97 ne patient suffered a lens injury due to the paracentesis, with subsequent need for cataract surgery.

98 without paracentesis, 36.4% of patients with paracentesis within 6 hours, 20% of patients with parace

99 entesis within 6 hours, 20% of patients with paracentesis within 7-24 hours, and 23.1% of patients wi

100 died from liver disease and had large-volume paracentesis within their last year of life.